EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart
From Jul 2019 to Jul 2024
EDAP TMS S.A. to Release 2004 Fourth Quarter and Year-End
Financial Results March 9, 2005
LYON, France, March 4 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP),
will release its fourth quarter and year-end financial results for the period
ending December 31, 2004 on Wednesday, March 9, 2005 after the market close.
The company will host a conference call to discuss the results and answer
questions from investors on Thursday, March 10, 2005, at noon Eastern Time,
6:00 p.m. Paris Time. Representing the Company on the call will be Philippe
Chauveau, Chairman of the Board, Hugues de Bantel, Chief Executive Officer, and
Thierry Turbant, Chief Financial Officer.
Interested investors may join the call live by dialing +1 (785) 832-2422 and
requesting the EDAP TMS 2004 Year End Conference Call. Investors may also
listen to the live call online at http://www.edap-tms.com/ .
Investors unable to join the call can access a playback of the conference call.
To access the replay, please dial +1 (402) 220-2332 beginning two hours after
the end of the call until Saturday, March 19, 2005, or visit the company's Web
site at http://www.edap-tms.com/ .
About EDAP TMS S.A.
EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically
proven choice for High Intensity Focused Ultrasound (HIFU) treatment of
localized prostate cancer. HIFU treatment is shown to be a minimally invasive
and effective treatment option with a low occurrence of side effects. The
company is also developing this technology for the treatment of certain other
types of tumors. EDAP TMS S.A. also produces and commercializes medical
equipment for treatment of urinary tract stones using Extra-corporeal Shockwave
Lithotripsy (ESWL).
For more information on the Company, contact the Investor Relations Dept by
phone at +33 (0)4 78 26 40 46 or see the Company's Web site at:
http://www.edap-tms.com/ .
This press release contains, in addition to historical information,
forward-looking statements that involve risks and uncertainties. These include
statements regarding the Company's growth and expansion plans. Such statements
are based on management's current expectations and are subject to a number of
uncertainties and risks that could cause actual results to differ materially
from those described in the forward-looking statements. Factors that may cause
such a difference include, but are not limited to, those described in the
Company's filings with the Securities and Exchange Commission.
CONTACT: EDAP TMS S.A.
Hugues de Bantel - Philippe Chauveau
Blandine Confort
+33 4 78 26 40 46
Halliburton Investor Relations
Matt Kreps - Geralyn DeBusk
972 458 8000
DATASOURCE: EDAP TMS S.A.
CONTACT: Hugues de Bantel, Philippe Chauveau or Blandine Confort, all of
EDAP TMS S.A., +33-4-78-26-40-46; or Matt Kreps or Geralyn DeBusk, both of
Halliburton Investor Relations, +1-972-458-8000, for EDAP TMS S.A.
Web site: http://www.edap-tms.com/